Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
Panagis M. Lykoudis(National and Kapodistrian University of Athens), Sandra Mallone(Istituto Superiore di Sanità), Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Guido Mazzoleni, Alice Nennecke, Jón G. Jónasson(Reykjavík University), Roberta De Angelis(Istituto Superiore di Sanità), Mario Šekerija(London Cancer), Martyn Caplin(The Royal Free Hospital), Marc Maynadié(Universidad de Granada), Giuseppe Fusai(The Royal Free Hospital), G. Schubert-Fritschle(Ludwig-Maximilians-Universität München), Pascale Grosclaude(Seoul National University Children's Hospital), Francesca Muffatti(Vita-Salute San Raffaele University), Florence Molinié, Bernd Holleczek(Krebsregister Saarland), Diego Serraino(Centro di Riferimento Oncologico), Brigitte Trétarre(Pancreatic Cancer Action Network), K. Henau, Massimo Falconi(Vita-Salute San Raffaele University), Anne‐Sophie Woronoff, Alain Monnereau, Stefano Partelli(Vita-Salute San Raffaele University), Michel Robaszkiewicz(Universidad de Granada), Maarit K. Leinonen(University of Helsinki), Véronique Bouvier(Inserm), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Nea Malila(Istituto Superiore di Sanità), Anne‐Valérie Guizard, Simona Bara(Centre Hospitalier Public du Cotentin), B. Lapôtre‐Ledoux(Fondazione IRCCS Istituto Nazionale dei Tumori), Monika Hackl(Universidad de Granada), Jan Heidrich(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), P. Arveux(Istituto Superiore di Sanità), Adriano Giacomin, Antonella Sutera Sardo, Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), E. Van Eycken(Istituto Superiore di Sanità), Alessandro Barchielli(Centro di Riferimento Oncologico), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Xavier Troussard, Jutta Engel(Universidad de Granada), Harry Comber(Universidad de Granada), Kerri M. Clough‐Gorr(Boston University), Isabelle Baldi(Pancreatic Cancer Action Network)
HAL (Le Centre pour la Communication Scientifique Directe)
October 1, 2017
Cited by 0
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k